5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase

https://doi.org/10.1016/j.bmcl.2008.11.048Get rights and content

Abstract

5,6-Dihydro-1H-pyridin-2-one analogs were discovered as a novel class of inhibitors of genotype 1 HCV NS5B polymerase. Among these, compound 4ad displayed potent inhibitory activities in biochemical and replicon assays (IC50 (1b) < 10 nM; IC50 (1a) < 25 nM, EC50 (1b) = 16 nM), good in vitro DMPK properties, as well as moderate oral bioavailability in monkeys (F = 24%).

Section snippets

Acknowledgement

The authors thank Drs. Devron Averett and Steve Worland for their support and helpful discussions during the course of this work.

References and notes (23)

  • C.W. Shepard et al.

    Lancet Infect. Dis.

    (2005)
  • F. Ruebsam et al.

    Bioorg. Med. Chem. Lett.

    (2008)
  • G. Bartoli et al.

    J. Org. Chem.

    (1994)
  • For additional experimental details, see: Tran, C. V.; Ruebsam, F.; Zhou, Y.; Dragovich, P. S.; Xiang, A. X. PCT...
  • C. Bolm et al.

    J. Org. Chem.

    (2000)
    C. Bolm et al.

    Synthesis

    (2001)
  • A.C.T. van Duin et al.

    J. Phys. Chem. A

    (2001)
  • (a)The calculations were performed using PC Gamess (Version 6) employing the HF/6-31g∗//MP2/6-31+g∗ level of theory....(b)The enol moiety present in structures 12 and 13 (or 4a) is presumed to be completely deprotonated under the basic...(c)The location of the benzothiadiazine NH proton in structures 12 and 13 reflects the most stable tautomer predicted...
  • Q.L. Choo et al.

    Science

    (1989)
  • Cited by (29)

    • Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking

      2021, Computers in Biology and Medicine
      Citation Excerpt :

      It is important to mention that irreversible inhibitors were excluded from the set. Collectively, these compounds represent the following scaffold classes: Benzothiadiazine, benzothiazine, 1,1-dioxoisothiazole, 5,6-dihydro-1H-pyridin-2-one, proline sulfonamide, acrylic acid, N-acyl pyrrolidine, benzamide, nicotinamide, anthranilic acid, benzodiazepine, sulphone and benzofuran [18,20–32]. For selecting a protein structure for the benchmarking study, we downloaded the NS5B structures from the PDB (Table S2 in SM).

    • Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors

      2011, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      These compounds displayed low to moderate in vivo clearance. Most of the compounds bearing aliphatic chains showed low stability towards monkey liver microsomes (MLM), while those with benzylic substituents (17b, 17c, 17f, 18b and 18c) were stable in the assay.100 The enantiopure inhibitor (4aR, 7aS)-17b showed a good combination of replicon potency and in vitro/in vivo DMPK properties and exhibited plasma levels in monkeys that significantly exceeded its replicon EC50 value for at least 12 h following oral dosing.

    • Synthesis, antitumor and antimicrobial activities of 4-(4-chlorophenyl)-3- cyano-2-(β-O-glycosyloxy)-6-(thien-2-yl)-nicotinonitrile

      2011, European Journal of Medicinal Chemistry
      Citation Excerpt :

      Pyridine derivatives have shown a broad spectrum of biological activities [1–3]. Pyridine derivatives and their nucleoside analogs showed strong cytotoxicity against several human cancer cell [4,5], potent and selective farnesyltransferase inhibitions [6] and inhibitors of HCV NS5B polymerase inhibitions [7], as well as antimicrobial [8], and antimycobacterial activities [9]. The pharmacological and physiological activity of 3-cyanopyridin-2(1H)-ones has attracted much attention in recent years.

    View all citing articles on Scopus
    View full text